MOZ, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.145
AS - Asia 6.179
EU - Europa 2.465
SA - Sud America 883
AF - Africa 779
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 53
AN - Antartide 1
Totale 19.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.635
SG - Singapore 1.959
VN - Vietnam 1.171
CN - Cina 1.151
BR - Brasile 587
HK - Hong Kong 536
IT - Italia 451
PL - Polonia 232
FI - Finlandia 222
BD - Bangladesh 215
FR - Francia 203
DE - Germania 175
SE - Svezia 167
IN - India 155
GB - Regno Unito 138
NL - Olanda 107
RU - Federazione Russa 104
CA - Canada 98
MX - Messico 75
UA - Ucraina 69
JP - Giappone 68
IQ - Iraq 66
TR - Turchia 65
SA - Arabia Saudita 62
AR - Argentina 60
PK - Pakistan 59
ID - Indonesia 58
ZA - Sudafrica 57
ES - Italia 50
BJ - Benin 47
EC - Ecuador 46
MY - Malesia 42
PH - Filippine 41
CO - Colombia 39
EG - Egitto 38
AT - Austria 37
KR - Corea 36
NP - Nepal 36
UZ - Uzbekistan 33
HR - Croazia 31
TN - Tunisia 31
CL - Cile 30
DK - Danimarca 30
LB - Libano 30
RO - Romania 30
PR - Porto Rico 29
BW - Botswana 28
KE - Kenya 28
GT - Guatemala 27
IE - Irlanda 27
JM - Giamaica 27
PT - Portogallo 27
VE - Venezuela 27
MA - Marocco 26
TH - Thailandia 26
CR - Costa Rica 25
JO - Giordania 25
KZ - Kazakistan 25
LY - Libia 25
AO - Angola 24
AZ - Azerbaigian 24
BB - Barbados 24
CY - Cipro 24
AU - Australia 23
BG - Bulgaria 23
GR - Grecia 23
PS - Palestinian Territory 23
AE - Emirati Arabi Uniti 22
BA - Bosnia-Erzegovina 22
CW - ???statistics.table.value.countryCode.CW??? 22
CZ - Repubblica Ceca 22
IR - Iran 22
KG - Kirghizistan 22
PY - Paraguay 22
UG - Uganda 22
ZM - Zambia 22
CI - Costa d'Avorio 21
GF - Guiana Francese 21
MD - Moldavia 21
CV - Capo Verde 20
GN - Guinea 20
PE - Perù 20
SK - Slovacchia (Repubblica Slovacca) 20
TZ - Tanzania 20
AL - Albania 19
BE - Belgio 19
EE - Estonia 19
HU - Ungheria 19
IL - Israele 19
LC - Santa Lucia 19
MZ - Mozambico 19
PA - Panama 19
TJ - Tagikistan 19
BZ - Belize 18
CH - Svizzera 18
CM - Camerun 18
DO - Repubblica Dominicana 18
DZ - Algeria 18
ET - Etiopia 18
KH - Cambogia 18
Totale 18.790
Salva come PNG Salva come JPEG
Città #
Singapore 1.262
Ashburn 1.233
San Jose 971
Fairfield 649
Woodbridge 611
Ann Arbor 573
Houston 545
Chandler 523
Hong Kong 457
Ho Chi Minh City 357
Hanoi 260
Cambridge 254
Wilmington 229
Seattle 224
Beijing 216
Bytom 180
Santa Clara 170
Los Angeles 165
Boardman 153
Jacksonville 139
Princeton 114
Des Moines 112
Helsinki 108
New York 104
Medford 102
Lauterbourg 100
Dong Ket 79
Padova 74
Nanjing 70
Da Nang 69
São Paulo 68
Buffalo 61
San Diego 54
Roxbury 53
Guangzhou 48
Haiphong 48
Cotonou 46
Tokyo 42
Shanghai 37
Redondo Beach 36
Chicago 34
Montreal 34
Milan 33
Munich 33
Orem 33
Dallas 32
Tashkent 31
Warsaw 30
Baghdad 29
Jinan 29
Rome 29
Shenyang 29
Frankfurt am Main 27
Changsha 26
London 26
Hebei 25
Johannesburg 25
Council Bluffs 24
Phoenix 24
Tianjin 24
Amsterdam 23
Gaborone 23
Nairobi 23
San Francisco 23
Amman 22
Dublin 22
Hải Dương 22
Kampala 22
Lusaka 22
Petaling Jaya 22
Riyadh 22
Toronto 22
Baku 21
Bridgetown 21
Brooklyn 21
Luanda 21
Nanchang 21
Stockholm 21
Vienna 21
Jeddah 20
New Delhi 20
Abidjan 19
Atlanta 19
Cairo 19
Conakry 19
Istanbul 19
Praia 19
San José 19
Bishkek 18
Biên Hòa 18
Castries 18
Chennai 18
Guatemala City 18
Panama City 18
Phnom Penh 18
Dakar 17
Dar es Salaam 17
Dushanbe 17
Managua 17
Manchester 17
Totale 11.972
Salva come PNG Salva come JPEG
Nome #
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 340
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 333
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 332
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 331
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 309
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 303
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 300
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 282
Emerging role of monocytes and of their intracellular calcium content in spondyloarthritis 268
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 265
Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study 264
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 261
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 260
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 259
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 258
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 252
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 251
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave 240
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 239
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 235
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 233
Vitamin D prevents pancreatic cancer-induced apoptosis signaling of inflammatory cells 231
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 226
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 225
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 223
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 223
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 216
VITAMIN D:FOE OF THE IMMUNE RESPONSE IN PANCREATIC CANCER 216
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 214
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 214
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 212
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 209
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 202
Emerging role of monocytes and their intracellular calcium pattern in spondyloarthritis 202
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 200
Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling 200
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 197
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 196
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 193
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 190
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 190
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 188
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 184
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 184
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 182
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 182
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 180
New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance 178
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 178
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 175
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 174
PRE-ANALYTICAL EFFECTS ON ESTABLISHED AND EMERGING BIOMARKERS OF CARDIOVASCULAR DISEASE (CVD) 173
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 173
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 172
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 171
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 169
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 169
Genome-wide association study identifies an early onset pancreatic cancer risk locus 169
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 167
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 167
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 166
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 166
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 164
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 161
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 161
NT-S100A8 effects on cell signalling. 158
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 158
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 157
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 152
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 150
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 146
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 145
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 144
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 143
The new commercial microarray inifiniti FMF test is feasible for the genetic diagnosis of familial mediterranean fever (FMF) in italian patients 142
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 142
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 140
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 139
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 139
Maldi-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and Complement C3. 138
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 138
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 137
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 134
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 134
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 132
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 131
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 131
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 129
Genome-wide association study identifies an early onset pancreatic cancer risk locus. 129
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 128
Effectiveness of the combined evaluation of KLK3 genetics and f/tPSA ratio for prostate cancer diagnosis 128
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 127
The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells 121
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 121
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 119
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 119
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 118
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 117
Polymorphic variants with non-coding RNA and risk of pancreatic ductal adenocarcinoma. 115
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 114
Totale 18.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.160
article - articoli 26.250
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022998 14 173 68 56 36 77 28 98 55 11 94 288
2022/20231.116 203 107 13 129 194 159 10 76 148 9 38 30
2023/2024649 21 70 66 50 47 64 64 77 21 50 51 68
2024/20252.633 15 133 131 124 321 58 145 220 231 108 490 657
2025/202610.145 470 770 1.212 1.105 1.054 394 1.816 934 1.112 589 396 293
2026/2027180 180 0 0 0 0 0 0 0 0 0 0 0
Totale 19.650